by Antimicrobial catheters are medical tubes inserted into the body for delivering and draining fluids in and out of the body. They are coated with antibiotics or antimicrobial agents to prevent bacterial infections. Catheter associated urinary tract infections (CAUTIs) are one of the most common types of healthcare-associated infections, accounting for up to 40% of all HAIs. Use of antimicrobial catheters is one of the most effective strategies to prevent CAUTIs. The global antimicrobial coatings prevent bacteria from adhering and colonizing on catheter surfaces. Some key advantages of antimicrobial catheters include reduced risk of infection, safety, effectiveness, and cost-savings for healthcare systems in the long run. The growing prevalence of hospital acquired infections and rising awareness about prevention of CAUTIs have increased the demand for antimicrobial catheters in recent years.
The global Antimicrobial Catheter Market is estimated to be valued at US$ 14505.18 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends in the antimicrobial catheter market is the growing preference for silver alloy coated products. Silver has proven antimicrobial properties and silver alloy coatings are very effective at preventing bacterial infections. Major players are focusing on developing innovative silver alloy coating technologies to further enhance the efficacy and duration of action. For instance, in 2021, BD received FDA clearance for its urinary catheter coated with TruRelease antimicrobial silver alloy technology. The novel coating is designed to gradually release silver ions for up to 30 days of protection against CAUTIs.
Porter’s Analysis
Threat of new entrants: The antimicrobial catheter market requires significant capital investment for R&D of new products and clinical trials, as well as production capacity, and distribution networks. These factors pose barriers for new players.
Bargaining power of buyers: Buyers in the antimicrobial catheter market include hospitals and healthcare facilities. Their bargaining power is moderate as there exist many global and regional level suppliers in the market offering catheter products at competitive prices.
Bargaining power of suppliers: The raw material suppliers for antimicrobial catheters include plastic, coating, and antimicrobial agents suppliers. Their bargaining power is moderate due to presence of several suppliers.
Threat of new substitutes: There exist substitute products like foley catheters, however they are not as effective as antimicrobial catheters in preventing CAUTI. This keeps threat of substitution low.
Competitive rivalry: The market is moderately competitive due to presence of numerous global and regional players. The key companies focus on new product launches and innovation to gain market share.
Key Takeaways
The Global Antimicrobial Catheter Market Size is expected to witness high growth over the forecast period owing to increasing prevalence of hospital acquired infections.
North America is expected to hold the largest share in the antimicrobial catheter market during the forecast period. This is attributed to factors such as growing geriatric population, increasing number of surgical procedures, rising prevalence of HAIs, and stringent regulations regarding patient safety and infection control in healthcare facilities.
Key players operating in the antimicrobial catheter market are Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc. The companies are focusing on new product launches, obtaining approvals, and strengthening their distribution networks to strengthen their market position.
